RIMA
Overview
Reversible inhibitors of monoamine oxidase A (RIMAs) are a class of drugs which selectively and reversibly inhibit the enzyme monoamine oxidase A (MAO-A). They are used clinically in the treatment of depression and dysthymia, though they have not gained widespread market share due to limited efficacy relative to other antidepressants. Because of their reversibility and selectivity, RIMAs are safer than the older monoamine oxidase inhibitors (MAOIs).[1] PW
Drugs in this class on intoxicant.wiki
Every page on this site that a cited source puts in this class: 8 pages. A drug is listed when PsychonautWiki's "RIMA" page, revision 160412 lists it, or when its own PsychonautWiki, TripSit or Wikipedia entry names this class. Each name opens our page for that drug; long chemical names are shown by a shorter name the drug is also known by (hover for the full name).
- 1-Ethyl-β-carboline WP
- 5-IT PW list
- Brofaromine WP
- Harmalacidine WP
- Harmaline PW list WP
- Metralindole WP
- Moclobemide PW list
- αMT PW list
Tags show who puts each drug in this class (hover for the exact wording): PW list = listed on PsychonautWiki's page for this class; PW = the drug's PsychonautWiki entry; TS = the drug's TripSit entry (drug category); WP = the drug infobox of the drug's Wikipedia article. These are classifications only, not dosage guidance.
References
- Journal / agency Fowler, J. S., Logan, J., Azzaro, A. J., Fielding, R. M., Zhu, W., Poshusta, A. K., Burch, D., Brand, B., Free, J., Asgharnejad, M., Wang, G.-J., Telang, F., Hubbard, B., Jayne, M., King, P., Carter, P., Carter, S., Xu, Y., Shea, C., Muench, L., Alexoff, D., Shumay, E., Schueller, M., Warner, D., Apelskog-Torres, K. Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157. Neuropsychopharmacology. February 2010. doi:10.1038/npp.2009.167
Text and values on this page are quoted from PsychonautWiki (CC BY-SA 4.0). Each value links to the exact revision it came from.